Del. Judge Rejects 'Flawed' HHS Pharmacy Discount Rule

By Jeff Montgomery · June 16, 2021, 7:48 PM EDT

A U.S. District Court judge in Delaware refused to dismiss on Wednesday an AstraZeneca Pharmaceuticals LP challenge to a Department of Health and Human Services finding that drug manufacturers can't limit...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

AstraZeneca Pharmaceuticals LP v. Xavier Becerra et al

Case Number

1:21-cv-00027

Court

Delaware

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

January 12, 2021

Recent Articles By Jeff

February 28, 2025
Bioventus Hit With Del. Derivative Suit After NC Class Deal
January 15, 2025
Del. Justices Mull 'Reasonable' Effort Duty In Drug Biz Deal
January 14, 2025
Chancery Hits Co. With $2.9M Atty Fee Bill As Sanction
December 03, 2024
Chancery Orders Revenue Trust For Healthcare Co. 'Poaching'
October 21, 2024
Apple Tells Del. Jury It Wants Smartwatch Infringing To Stop
September 06, 2024
Biopharm Co., Directors Sued In Del. Over 'Extreme' Scheme
September 04, 2024
J&J Hit With $1B Damages In Del. Merger Milestone Fight
July 18, 2024
Air Transport Co. Sued In Del. Over Director Removal Rule
July 16, 2024
Chancery Orders Illumina Docs Released In Grail Merger Fight
May 20, 2024
Healthcare Futures Co. Sues Breakaway Ex-Members In Del.